Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents

Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents

OBJECTIVE: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and North-American algorithms for the treatment of multiple sclerosis do not foresee our regional difficulties and the access of patients to treatment. METHODS: The Latin A...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandro Finkelsztejn, Alberto Alain Gabbai, Yara Dadalti Fragoso, Adriana Carrá, Miguel Angel Macías-Islas, Raul Arcega-Revilla, Juan García-Bonitto, Carlos Luis Oehninger-Gatti, Geraldine Orozco-Escobar, Adriana Tarulla, Fernando Vergara, Darwin Vizcarra
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações 2012-10-01
Series:	Arquivos de Neuro-Psiquiatria
Subjects:	esclerose múltipla tratamento América Latina
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2012001000009&lng=en&tlng=en
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Guideline for multiple sclerosis treatment in Brazil: Consensus from the Neuroimmunology Scientific Department of the Brazilian Academy of Neurology
by: Elizabeth Regina Comini-Frota, et al.

Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: III. Diretrizes baseadas em evidências e recomendações
by: Lana-Peixoto Marco Aurélio, et al.
Published: (2002-01-01)

Medication withdrawal may be an option for a select group of patients in relapsing-remitting multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2013-08-01)

The effect of multiple sclerosis on the professional life of a group of Brazilian patients
by: Yára Dadalti Fragoso, et al.
Published: (2010-12-01)

The internet racing ahead of the scientific evidence: the case of "liberation treatment" for multiple sclerosis
by: Yára Dadalti Fragoso
Published: (2011-06-01)

Patients with multiple sclerosis present low levels of empathy
by: Marcos Barbosa de Almeida, et al.

Assessment of cognition using the Rao's Brief Repeatable Battery of Neuropsychological Tests on a group of Brazilian patients with multiple sclerosis
by: Joseph Bruno Bidin Brooks, et al.
Published: (2011-12-01)

Restless legs syndrome and multiple sclerosis: a Brazilian multicenter study and meta-analysis of the literature
by: Yára Dadalti Fragoso, et al.
Published: (2011-04-01)

Interferon beta 1-a na esclerose múltipla: experiência de um ano em 62 pacientes
by: CHARLES P. TILBERY, et al.
Published: (2000-06-01)

The prevalence of multiple sclerosis in Santa Maria, Rio Grande do Sul, Brazil
by: Alessandro Finkelsztejn, et al.
Published: (2014-02-01)

Correlation between fatigue and self-esteem in patients with multiple sclerosis Correlação entre gravidade da fadiga e baixa estima na esclerose múltipla
by: Yára Dadalti Fragoso, et al.
Published: (2009-09-01)

Paced auditory serial addition test (PASAT): a very difficult test even for individuals with high intellectual capability
by: Joseph Bruno Bidin Brooks, et al.
Published: (2011-06-01)

Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis
by: Dóra-Neide Rodrigues, et al.
Published: (2011-08-01)

Ressonância magnética na esclerose múltipla: análise de 270 casos
by: Guilberto Minguetti
Published: (2001-09-01)

Balance Rehabilitation Unit (BRU TM) posturography in relapsing-remitting multiple sclerosis
by: Natália Kessler, et al.
Published: (2011-06-01)

Effect of 12 weeks of aquatic strength training on individuals with multiple sclerosis
by: Claudio SCORCINE, et al.
Published: (2022-02-01)

Immunomodulator therapy migration in relapsing remitting multiple sclerosis: a study of 152 cases Migração medicamentosa de imunomoduladores em esclerose múltipla: estudo em 152 pacientes
by: Sergio Semeraro Jordy, et al.
Published: (2008-03-01)

Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: II. As evidências para o uso de glicocorticóides e imunomoduladores The BCTRIMS expanded consensus on treatment of multiple sclerosis: II. The evidences for the use of glucocorticoids and immunomodulatory treatments
by: Marcos Aurélio Moreira, et al.
Published: (2002-09-01)

Esclerose múltipla: estudo clínico de 50 pacientes acompanhados no Ambulatório de Neurologia UNIFESP-EPM
by: OLIVEIRA ENEDINA MARIA LOBATO DE, et al.
Published: (1999-01-01)

The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2014-09-01)

Description and characteristics of 81 patients attending the Reference Center for Multiple Sclerosis of the coastal region of the state of São Paulo - Brazil Descrição e características dos 81 pacientes em seguimento no Centro de Referência em Esclerose Múltipla do litoral paulista
by: Yara Dadalti Fragoso, et al.
Published: (2005-09-01)

Tolerability, adverse events and compliance to glatiramer acetate in 28 patients with multiple sclerosis using the drug continuously for at least six months Tolerabilidade, eventos adversos e aderência ao acetato de glatiramer em 28 pacientes com esclerose múltipla usando a droga continuamente por pelo menos seis meses
by: Ana Patricia Perez Fiore, et al.
Published: (2005-09-01)

Consenso expandido do BCTRIMS para o tratamento da esclerose múltipla: I. As evidências para o uso de imunossupressores, plasmaférese e transplante autólogo de células tronco
by: Dagoberto Callegaro, et al.
Published: (2002-09-01)

Multiple sclerosis starting before the age of 18 years: the Brazilian experience
by: Yara Dadalti Fragoso, et al.
Published: (2013-10-01)

Reabilitação vestibular em pacientes com esclerose múltipla remitente-recorrente Vestibular rehabilitation in patients with relapsing- remitting multiple sclerosis
by: Karina Pavan, et al.
Published: (2007-06-01)

Patients with multiple sclerosis do not necessarily consume more alcohol or tobacco than the general population
by: Yara Dadalti Fragoso, et al.
Published: (2015-10-01)

Influence of treatment in multiple sclerosis dysability: an open, retrospective, non-randomized long-term analysis Influência do tratamento na incapacidade da esclerose múltipla: estudo aberto, retrospectivo e não randomizado em longo prazo
by: Lineu Cesar Werneck, et al.
Published: (2010-08-01)

Sight-dependent quality of life and ophthalmic findings in a group of Brazilian patients with multiple sclerosis
by: Yára Dadalti Fragoso, et al.
Published: (2011-10-01)

No correlation was observed between vitamin D levels and disability of patients with multiple sclerosis between latitudes 18° and 30° South
by: Yara Dadalti Fragoso, et al.

Safety of switching from natalizumab straight into fingolimod in a group of JCV-positive patients with multiple sclerosis
by: Yara Dadalti Fragoso, et al.
Published: (2016-08-01)

Attention impairment associated with relapsing-remitting multiple sclerosis patients with mild incapacity Prejuízo da atenção em pacientes com esclerose múltipla na forma remitente-recorrente com incapacidade leve
by: Silvia Balsimelli, et al.
Published: (2007-06-01)

Multiple sclerosis in South America: month of birth in different latitudes does not seem to interfere with the prevalence or progression of the disease
by: Yara Dadalti Fragoso, et al.
Published: (2013-09-01)

Patients’ satisfaction with and views about treatment with disease-modifying drugs in multiple sclerosis
by: Caroline Vieira Spessotto, et al.
Published: (2016-08-01)

Esclerose múltipla, ependimoma medular e meningioma intracraniano: relato de caso
by: MÔNICA F. COSTA, et al.
Published: (2000-12-01)

Nomeação e fluência verbal em portadores de Esclerose Múltipla = Naming and verbal fluency in patients with Multiple Sclerosis
by: Guaresi, Ronei
Published: (2013-01-01)

Clinical and epidemiological profile of patients with multiple sclerosis in Uberaba, Minas Gerais, Brazil
by: Sônia Beatriz Félix Ribeiro, et al.
Published: (2011-04-01)

Benign multiple sclerosis: aspects of cognition and neuroimaging
by: Alyne Mendonça Marques Ton, et al.

Prevalence of multiple sclerosis in Goiânia, Goiás, Brazil
by: Taysa Alexandrino Gonsalves Jubé Ribeiro, et al.

Clinical predictors of response to immunomodulators for multiple sclerosis
by: Guilherme Sciascia do Olival, et al.
Published: (2012-01-01)

Esclerose múltipla simulando tumor cerebral: apresentação de caso com comprovação histopatológica
by: Charles Peter Tilbery, et al.
Published: (1995-06-01)